Verastem, Inc.

NASDAQ:VSTM

2.4 (USD) • At close September 6, 2024
Bedrijfsnaam Verastem, Inc.
Symbool VSTM
Munteenheid USD
Prijs 2.4
Beurswaarde 96,584,880
Dividendpercentage 0%
52-weken bereik 2.1 - 14.22
Industrie Biotechnology
Sector Healthcare
CEO Mr. Daniel W. Paterson
Website https://www.verastem.com

An error occurred while fetching data.

Over Verastem, Inc.

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages

Vergelijkbare Aandelen

Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc.

VYGR

6.13 USD

Theratechnologies Inc. logo

Theratechnologies Inc.

THTX

1.225 USD

Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.

OCUL

8.39 USD

ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc.

CLPT

11.89 USD

4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.

FDMT

15.07 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)